Cinctive Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
156,228
+59,278
| +61% | +$4.64M | 0.65% | 38 |
|
|
2025
Q1 | $7.03M | Sell |
96,950
-51,973
| -35% | -$3.77M | 0.54% | 51 |
|
|
2024
Q4 | $11M | Buy |
148,923
+92,963
| +166% | +$6.88M | 0.56% | 42 |
|
|
2024
Q3 | $3.69M | Buy |
+55,960
| New | +$3.69M | 0.2% | 158 |
|
|
2024
Q2 | – | Sell |
-33,333
| Closed | -$3.19M | – | 408 |
|
|
2024
Q1 | $3.19M | Buy |
+33,333
| New | +$3.19M | 0.15% | 165 |
|
|
2023
Q1 | – | Sell |
-41,599
| Closed | -$3.1M | – | 435 |
|
|
2022
Q4 | $3.1M | Buy |
+41,599
| New | +$3.1M | 0.15% | 200 |
|
|
2022
Q3 | – | Sell |
-25,560
| Closed | -$2.43M | – | 481 |
|
|
2022
Q2 | $2.43M | Sell |
25,560
-12,064
| -32% | -$1.15M | 0.1% | 264 |
|
|
2022
Q1 | $4.43M | Sell |
37,624
-34,309
| -48% | -$4.04M | 0.16% | 178 |
|
|
2021
Q4 | $9.32M | Buy |
71,933
+62,110
| +632% | +$8.05M | 0.41% | 71 |
|
|
2021
Q3 | $1.11M | Sell |
9,823
-57,006
| -85% | -$6.45M | 0.05% | 357 |
|
|
2021
Q2 | $6.92M | Buy |
66,829
+64,212
| +2,454% | +$6.65M | 0.32% | 87 |
|
|
2021
Q1 | $219K | Buy |
+2,617
| New | +$219K | 0.01% | 386 |
|